Nordic Capital and Permira Propose $3 Billion Takeover of Bavarian Nordic, Shares Rise 24% as Company to Go Private

Danish biotech company Bavarian Nordic, known for its vaccine development, is in advanced discussions to be acquired by a consortium led by private equity firms Nordic Capital and Permira. The takeover offer is valued at approximately $3 billion. Following the announcement of the potential deal, Bavarian Nordic's share price rose by 24%. The agreement would take the company private, with the consortium aiming to buy all outstanding shares. The discussions and subsequent offer highlight growing private equity interest in the vaccine sector.